Blog

White Paper Issue 18: Bringing Patients to Treatments

Patient frustration with the lack of ALS treatment options and the progression of compounds through the drug delivery pipeline is evident...

Sayuri Miyamoto to present a poster at the Paris Redox 2022 World Conference

NDR is pleased to congratulate Dr. Sayuri Miyamoto and her co-workers Adriano Chaves-Filho, Rosangela Santos, Rodrigo Lima, Larissa...

Cornerstone for ALS Researchers

We are pleased to announce that Dr. Steve Pelech, Kinexus Bioinformatics Corp, completed a long time goal with funding help from NDR....

White Paper Issue 17: Effectiveness of levamisole HCl and thymalfasin in two mouse models of ALS

Levamisole HCl and Zadaxin tested in two mouse models of ALS

Research notes from Dr. Miyamoto

We are pleased to let you hear Dr. Sayuri Myiamoto present her preliminary work, listen to the video. There is a lot more to learn, and...

White Paper Issue 16: Seeing ALS

Could optical coherence tomography be useful in stratifying ALS patients? Ocular nerves are specialized connections to the central...

White Paper Issue 15: Are in vitro Neuronal Cells Models for ALS discovery?

in vitro neuronal cells considered for ALS drug discovery

Welcome Dr. Anthony Akkari

We welcome Dr. Anthony Akkari, newest member to our scientific discussion group at NDR. He wears three professional hats. Dr. Akkari is a...